May 20th, 2022
Northpond Labs funds second Wyss Institute research project
Through the Laboratory for Bioengineering Research and Innovation, Northpond will sponsor SomaCode to support commercialization
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
April 28th, 2022
CytoTronics launches to tackle drug discovery and phenotypic screening
Startup advances a unique CMOS-powered drug discovery platform that opens a new dimension in cell-based screening
March 15th, 2022
Making steak from vegetable protein
Harvard researchers spin ‘muscle’ fibers from vegetable plant proteins, launching alternative meat start-up
March 7th, 2022
Wyss Institute’s eRapid sensor technology licensed to Antisoma Therapeutics
Low-cost, multiplexed, electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics
February 23rd, 2022
Cantex licenses IP from Harvard to develop repurposed drug identified by Wyss Institute to treat inflammatory lung diseases including COVID-19
Organ Chip studies revealed azeliragon can reduce virus-associated inflammation in human lung tissue
